2C-T-19

2C-T-19, also known as 4-butylthio-2,5-dimethoxyphenethylamine, is a psychedelic phenethylamine of the 2C family. It was first synthesized by Alexander Shulgin.

2C-T-19

Clinical data
Other names	4-Butylthio-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-butylthiophenethylamine; 2C-T-Bu
ATC code	None
Identifiers
IUPAC name 2-[4-(butylsulfanyl)-2,5-dimethoxyphenyl]ethan-1-amine
CAS Number	732244-33-6 Y
PubChem CID	12063257
ChemSpider	21106235 Y
UNII	H190WE556H
CompTox Dashboard (EPA)	DTXSID10476737
Chemical and physical data
Formula	C14H23NO2S
Molar mass	269.40 g·mol−1
3D model (JSmol)	Interactive image
SMILES COc1cc(SCCCC)c(cc1CCN)OC
InChI InChI=1S/C14H23NO2S/c1-4-5-8-18-14-10-12(16-2)11(6-7-15)9-13(14)17-3/h9-10H,4-8,15H2,1-3H3 Y Key:LGUVDOBGXUFUAJ-UHFFFAOYSA-N Y
(verify)

Use and effects

In his book PiHKAL, Shulgin describes synthesis of the final intermediate of 2C-T-19 but did not bioassay the compound.^[1]

Society and culture

Legal status

Canada

As of October 31, 2016, 2C-T-19 is a controlled substance (Schedule III) in Canada.^[2]

United States

In the United States, 2C-T-19 is not specifically scheduled, but possession and sales of 2C-T-19 could be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7.

See also

• 2C (psychedelics)